Tenofovir Export Market Intelligence: India's 296 Suppliers Shipping to 182 Countries — TransData Nexus 2026

Q: Who are the top tenofovir exporters from India?

The top tenofovir exporters from India are: 1. MACLEODS PHARMACEUTICALS LTD — $3.3B (75.1% market share); 2. HETERO LABS LIMITED — $589.0M (13.6% market share); 3. MYLAN LABORATORIES LIMITED — $165.9M (3.8% market share); 4. STRIDES PHARMA SCIENCE LIMITED — $60.7M (1.4% market share); 5. EMCURE PHARMACEUTICALS LIMITED — $56.8M (1.3% market share). Together they account for 95.3% of India's total tenofovir export value.

Q: What is the total export value of tenofovir from India?

The total export value of tenofovir from India is $4.3B USD, recorded across 7,518 shipment transactions from 296 active exporters to 182 destination countries. The average shipment value is $575.8K.

Q: Which countries import tenofovir from India?

India exports tenofovir to 182 countries worldwide. The top importing countries are: BOTSWANA (73.3% share, $3.2B), TANZANIA (6.1% share, $264.4M), KENYA (4.1% share, $175.5M), SOUTH AFRICA (2.7% share, $115.2M), MOZAMBIQUE (1.9% share, $81.7M). These five markets account for 88.0% of total export value.

Q: What is the HS code for tenofovir exports from India?

The primary HS code for tenofovir exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of tenofovir exports from India?

The average unit price for tenofovir exports from India is $9.60 USD per unit, with prices ranging from $0.00 to $9690.00 depending on formulation, packaging, and order volume. The total market is valued at $4.3B across 7,518 shipments.

Q: Which ports handle tenofovir exports from India?

The primary ports for tenofovir exports from India are SAHAR AIR (18.0% of shipments), SAHAR AIR CARGO ACC (INBOM4) (14.9% of shipments), NHAVA SHEVA SEA (INNSA1) (7.0% of shipments), DELHI AIR CARGO ACC (INDEL4) (6.2% of shipments), HYDERABAD AIR (6.0% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of tenofovir?

India is one of the world's leading exporters of tenofovir due to its large base of 296 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports tenofovir to 182 countries, demonstrating 93% global market coverage.

Q: What certifications do Indian tenofovir exporters need?

Indian tenofovir exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import tenofovir from India?

There are 1,436 registered buyers importing tenofovir from India, spread across 182 countries. The repeat buyer rate is 59.6%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top tenofovir supplier from India?

MACLEODS PHARMACEUTICALS LTD is the leading tenofovir exporter from India with a market share of 75.1% and total export value of $3.3B across 519 shipments. The top 5 suppliers together control 95.3% of total export value.

Suresh Sormare

Tenofovir

India Pharmaceutical Trade Intelligence

$4.3B296 Suppliers182 CountriesHS 30049099

ExportsIndia → BOTSWANA73.3%India → TANZANIA6.1%

ImportsISRAEL → India$20.5M UNITED STATES → India$1.1M

#1 Buyer: AFRICURE PHARMACEUTICALS

Tenofovir Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Tenofovir to the World

Between 2022 and 2026, India exported $4.3B worth of tenofovir across 7,518 verified shipments to 182 countries — covering 93% of world markets in the Antiviral & HIV Medications segment. The largest destination is BOTSWANA (73.3%). MACLEODS PHARMACEUTICALS LTD leads with a 75.1% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published May 2026·Updated May 2026·

Tenofovir export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Tenofovir export data snapshot — $4.3B · 296 exporters · 182 countriesTransData Nexus · Indian Customs Data

Top Tenofovir Exporters from India

296 active exporters · Ranked by export value

View all 296 →

Top Tenofovir Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	MACLEODS PHARMACEUTICALS LTD	$3.3B	519	74	75.1%
2	HETERO LABS LIMITED

Top Countries Importing Tenofovir from India

182 destination markets · Ranked by import value

All 182 countries →

Top Countries Importing Tenofovir from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	BOTSWANA	$3.2B	73.3%
2	TANZANIA	$264.4M	6.1%
3	KENYA	$175.5M	4.1%
4	SOUTH AFRICA	$115.2M	2.7%
5	MOZAMBIQUE	$81.7M	1.9%
6	TOGO	$67.4M	1.6%
7	NIGERIA	$46.4M	1.1%
8	ZIMBABWE	$36.6M	0.8%
9	UNITED KINGDOM	$25.1M	0.6%
10	ETHIOPIA	$21.0M	0.5%

BOTSWANA is India's largest tenofovir export destination, absorbing 73.3% of total exports worth $3.2B. The top 5 importing countries — BOTSWANA, TANZANIA, KENYA, SOUTH AFRICA, MOZAMBIQUE — together account for 88.0% of India's total tenofovir export value. The remaining 177 destination countries collectively receive the other 12.0%, indicating a well-diversified global distribution network spanning all major continents.

Who Supplies Tenofovir to India?

20 origin countries · Total import value: $22.9M

India imports tenofovir from 20 countries with a combined import value of $22.9M. The largest supplier is ISRAEL ($20.5M, 10 shipments), followed by UNITED STATES and CANADA. All values are from Indian Customs (DGFT) import records.

Countries Supplying Tenofovir to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	ISRAEL	$20.5M	10	89.5%
2	UNITED STATES	$1.1M	75	4.9%
3	CANADA	$910.5K	25	4.0%
4	UNITED KINGDOM	$93.3K	14	0.4%
5	NETHERLANDS	$69.1K	7	0.3%
6	GERMANY	$55.1K	10	0.2%
7	IRELAND	$49.6K	6	0.2%
8	SINGAPORE	$25.6K	8	0.1%
9	SOUTH AFRICA	$17.5K	26	0.1%
10	BELGIUM	$17.0K	4	0.1%

Showing top 10 of 20 origin countries

ISRAEL is the largest supplier of tenofovir to India, accounting for 89.5% of total import value. The top 5 origin countries — ISRAEL, UNITED STATES, CANADA, UNITED KINGDOM, NETHERLANDS — together supply 99.1% of India's tenofovir imports. Click any country to see detailed supplier and buyer data for that import corridor.

Tenofovir — Export Intelligence Video

Visual overview of India's tenofovir import and export market — top suppliers, destinations, pricing, and trade routes

This video covers India's tenofovir pharmaceutical import and export market — $4.3B in total trade, 296 verified manufacturers, and 182 destination countries. Data sourced from Indian Customs (DGFT) shipment records.

Regulatory Landscape — Tenofovir

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

Tenofovir, a key antiretroviral agent, has been widely approved in the United States through numerous Abbreviated New Drug Applications (ANDAs). According to the FDA's Orange Book, multiple generic versions of tenofovir disoproxil fumarate have received approval, facilitating broad access to this essential medication. Notably, on March 24, 2010, the FDA approved Viread (tenofovir disoproxil fumarate) for the treatment of HIV infection in combination with other antiretroviral agents in patients aged 12 to less than 18 years. This approval was granted orphan drug designation on March 17, 2009, underscoring its importance in pediatric HIV treatment.

The substantial number of approved ANDAs reflects a competitive market landscape, aligning with the presence of 296 active Indian exporters of tenofovir. This robust exporter base underscores India's significant role in supplying tenofovir to the U.S. market. As of the current date, there are no active FDA import alerts specifically targeting tenofovir products from India, indicating compliance with U.S. regulatory standards.

2EU & UK Regulatory Framework

In the European Union, tenofovir-containing products have secured marketing authorizations through the European Medicines Agency (EMA). For instance, Emtricitabine/Tenofovir disoproxil Zentiva received EU-wide approval on November 9, 2016, for the treatment of HIV-1 infection. (ema.europa.eu) Similarly, Emtricitabine/Tenofovir alafenamide Viatris was authorized on July 18, 2025, expanding treatment options for HIV-1 infected adults and adolescents. (ema.europa.eu)

The United Kingdom, through the Medicines and Healthcare products Regulatory Agency (MHRA), adheres to stringent guidelines for the approval of antiretroviral medications, ensuring that tenofovir products meet high standards of safety, efficacy, and quality. Compliance with EU Good Manufacturing Practice (GMP) requirements is mandatory for manufacturers, encompassing rigorous quality control measures and regular inspections to maintain product integrity.

3WHO Essential Medicines & Global Standards

Tenofovir is included in the World Health Organization's (WHO) Model List of Essential Medicines, highlighting its critical role in global health. The WHO Prequalification Programme has also assessed and prequalified various tenofovir products, ensuring they meet international standards for quality, safety, and efficacy. Additionally, tenofovir formulations are standardized across major pharmacopoeias, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), facilitating consistent quality benchmarks worldwide.

4India Regulatory Classification

In India, tenofovir is classified under Schedule H of the Drugs and Cosmetics Act, indicating that it is a prescription-only medication. The National Pharmaceutical Pricing Authority (NPPA) has set ceiling prices for tenofovir formulations to ensure affordability; for example, the ceiling price for tenofovir disoproxil fumarate 300 mg tablets was established in March 2025. Export of tenofovir from India requires a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT), ensuring compliance with national regulations and monitoring of pharmaceutical exports.

5Patent & Exclusivity Status

The primary patents for tenofovir have expired, leading to increased generic competition and a diversified market. This has enabled numerous manufacturers, including Indian pharmaceutical companies, to produce and export tenofovir, contributing to its widespread availability and affordability globally.

6Recent Industry Developments

In August 2025, the EMA granted marketing authorization for Emtricitabine/Rilpivirine/Tenofovir Alafenamide Viatris, expanding treatment options for HIV-1 infection. (ema.europa.eu) In July 2025, the EMA approved Emtricitabine/Tenofovir alafenamide Viatris for the treatment of HIV-1 infection in adults and adolescents. (ema.europa.eu) In June 2025, the EMA adopted a positive opinion for Emtricitabine/Rilpivirine/Tenofovir Alafenamide Viatris, recommending its approval for HIV-1 treatment. (ema.europa.eu) In May 2025, the EMA adopted a positive opinion for Emtricitabine/Tenofovir alafenamide Viatris, recommending its approval for HIV-1 treatment. (ema.europa.eu) In March 2025, the NPPA revised the ceiling price for tenofovir disoproxil fumarate 300 mg tablets to enhance affordability.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Tenofovir

Retail & reference prices across 9 markets vs. India FOB export price of $9.60/unit

Global Price Benchmark for Tenofovir across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$2.14	USD	According to the FDA Orange Book, generic versions of TDF are available, contributing to competitive pricing.
United Kingdom	$2.14	GBP	The British National Formulary (BNF) lists TDF as available for prescription within the National Health Service (NHS).
Germany	$2.14	EUR	The European Medicines Agency (EMA) has approved generic versions of TDF, facilitating access within the European Union.
Australia	$2.14

Supply Chain Risk Assessment — Tenofovir

API sourcing, concentration risk, storage requirements, and current alerts

MEDIUM RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry heavily relies on China for Key Starting Materials (KSMs) and Active Pharmaceutical Ingredients (APIs), with approximately 60–70% of these materials imported from China. This dependency poses significant risks, as disruptions in Chinese supply chains can directly impact India's pharmaceutical production. For instance, environmental regulations in China have led to the shutdown of several chemical manufacturing units, causing supply uncertainties and price volatility for Indian pharmaceutical companies.

To mitigate these risks, the Indian government has implemented the Production Linked Incentive (PLI) Scheme for Bulk Drugs, aiming to promote domestic manufacturing of critical KSMs, DIs, and APIs. As of September 2025, this initiative has resulted in the establishment of manufacturing capacity for 26 KSMs/APIs, leading to cumulative sales of ₹2,315 crore and avoiding imports worth ₹1,807 crore.

2Supplier Concentration & Single-Source Risk

The Tenofovir export market is highly concentrated, with the top five exporters accounting for 95.3% of the market share. MACLEODS PHARMACEUTICALS LTD alone holds a 75.1% share, indicating a significant single-source risk. Any operational disruptions within these key suppliers could severely impact the global availability of Tenofovir.

The PLI Scheme for Pharmaceuticals, launched in March 2021, aims to diversify the supplier base by encouraging new entrants and expanding existing capacities. The scheme has a financial outlay of ₹6,940 crore and covers 41 products, including critical KSMs, DIs, and APIs. However, the effectiveness of this scheme in reducing supplier concentration for Tenofovir remains to be fully realized.

Access Complete Tenofovir Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 7,518 transactions across 182 markets.

Request Demo View Pricing

Frequently Asked Questions — Tenofovir Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top tenofovir exporters from India?

The leading tenofovir exporters from India are MACLEODS PHARMACEUTICALS LTD, HETERO LABS LIMITED, MYLAN LABORATORIES LIMITED, and 11 others. MACLEODS PHARMACEUTICALS LTD leads with 75.1% market share ($3.3B). The top 5 suppliers together control 95.3% of total export value.

What is the total export value of tenofovir from India?

The total export value of tenofovir from India is $4.3B, recorded across 7,518 shipments from 296 active exporters to 182 countries. The average shipment value is $575.8K.

Which countries import tenofovir from India?

India exports tenofovir to 182 countries. The top importing countries are BOTSWANA (73.3%), TANZANIA (6.1%), KENYA (4.1%), SOUTH AFRICA (2.7%), MOZAMBIQUE (1.9%), which together account for 88.0% of total export value.

What is the HS code for tenofovir exports from India?

The primary HS code for tenofovir exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Tenofovir

Tenofovir

Top Tenofovir Exporters from India

Top Countries Importing Tenofovir from India

Who Supplies Tenofovir to India?

Quick Facts

Related Antiviral & HIV Medications

Related Analysis

Need Details?

Tenofovir — Export Intelligence Video

Regulatory Landscape — Tenofovir

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Tenofovir

Supply Chain Risk Assessment — Tenofovir

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Tenofovir Trade Intelligence

Frequently Asked Questions — Tenofovir Exports from India

Who are the top tenofovir exporters from India?

What is the total export value of tenofovir from India?

Which countries import tenofovir from India?

What is the HS code for tenofovir exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of tenofovir exports from India?

Which ports handle tenofovir exports from India?

Why is India a leading exporter of tenofovir?

What certifications do Indian tenofovir exporters need?

How many buyers import tenofovir from India?

What is the market share of the top tenofovir exporter from India?

Analysis Methodology